References
- Sato AK, Viswanathan M, Kent RB, Wood CR. (2006). Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol, 17:638–642.
- Kim YJ, Doyle ML. (2010). Structural mass spectrometry in protein therapeutics discovery. Anal Chem, 82:7083–7089.
- Cleland JL, Daugherty A, Mrsny R. (2001). Emerging protein delivery methods. Curr Opin Biotechnol, 12:212–219.
- Brown LR. (2005). Commercial challenges of protein drug delivery. Expert Opin Drug Deliv, 2:29–42.
- Shalaby WS. (1995). Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin Immunol Immunopathol, 74:127–134.
- Uddin AN, Bejugam NK, Gayakwad SG, Akther P, D’Souza MJ. (2009). Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target, 17:553–560.
- Goldberg M, Gomez-Orellana I. (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov, 2:289–295.
- Carino GP, Mathiowitz E. (1999). Oral insulin delivery. Adv Drug Deliv Rev, 35:249–257.
- Jain D, Panda AK, Majumdar DK. (2005). Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech, 6:E100–E107.
- Nafissi-Varcheh N, Erfan M, Aboofazeli R. (2008). An approach to the design of a particulate system for oral protein delivery. I. In vitro stability of various poly (alpha-hydroxy acids)-microspheres in simulated gastrointestinal fluids. J Microencapsul, 25:584–592.
- Jeffrey L. Cleland RL. 1994. Formulation and delivery of proteins and peptides, Acs Symposium Series.
- Raymond T, Bartus, M. A. T., Dwaine F Emerich, and Stephen E. Zale 1998. Sustained delivery of proteins for novel therapeutic Products. Science. Highwire Press.
- Fu K, Klibanov AM, Langer R. (2000). Protein stability in controlled-release systems. Nat Biotechnol, 18:24–25.
- Bejugam NK, Uddin AN, Gayakwad SG, D’Souza MJ. (2008). Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul, 25:577–583.
- Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. (2002). Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm, 240:103–114.
- Billon A, Bataille B, Cassanas G, Jacob M. (2000). Development of spray-dried acetaminophen microparticles using experimental designs. Int J Pharm, 203:159–168.
- Rafat M, Cléroux CA, Fong WG, Baker AN, Leonard BC, O’Connor MD et al. (2010). PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells. Biomaterials, 31:3414–3421.
- Malzert-Fréon A, Hennequin D, Rault S. (2010). Partial least squares analysis and mixture design for the study of the influence of composition variables on lipidic nanoparticle characteristics. J Pharm Sci, 99:4603–4615.
- Jain D, Majumdar DK, Panda AK. (2006). Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. J Biomater Appl, 21:195–211.
- Akhgari A, Farahmand F, Afrasiabi Garekani H, Sadeghi F, Vandamme TF. (2006). Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Eur J Pharm Sci, 28:307–314.
- Lee DW, Hwang SJ, Park JB, Park HJ. (2003). Preparation and release characteristics of polymer-coated and blended alginate microspheres. J Microencapsul, 20:179–192.
- Ishida M, Abe K, Hashizume M, Kawamura M. (2008). A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules. Int J Pharm, 359:46–52.
- Mehuys E, Vervaet C, Remon JP. (2004). Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire core for sustained drug delivery. J Control Release, 94:273–280.
- Abd El-Hameed MD, Kellaway IW. (1997). Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur J Pharmaceut Biopharmaceut, 44:7.
- Putney SD, Burke PA. (1998). Improving protein therapeutics with sustained-release formulations. Nat Biotechnol, 16:153–157.
- Lennart Eriksson EJ, Wikstrom C. (1998). Mixture design—design generation, Pls analysis, and model usage. Chemometrics and Intelligent Laboratory Systems, 43: 24.
- Makhlof A, Werle M, Tozuka Y, Takeuchi H. (2010). Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int J Pharm, 397:92–95.
- Martin L, Wilson CG, Koosha F, Uchegbu IF. (2003). Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm, 55:35–45.
- Derakhshandeh K, Erfan M, Dadashzadeh S. (2007). Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm, 66:34–41.
- Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. (2003). Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm, 253:13–22.
- Martinello T, Kaneko TM, Velasco MV, Taqueda ME, Consiglieri VO. (2006). Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design. Int J Pharm, 322:87–95.